• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Reg IV和claudin-18的免疫组织化学染色在胃肠道印戒细胞癌的诊断中具有重要作用。

Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.

作者信息

Sentani Kazuhiro, Oue Naohide, Tashiro Takashi, Sakamoto Naoya, Nishisaka Takashi, Fukuhara Toshiyuki, Taniyama Kiyomi, Matsuura Hiroo, Arihiro Koji, Ochiai Atsushi, Yasui Wataru

机构信息

Department of Molecular Pathology, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.

出版信息

Am J Surg Pathol. 2008 Aug;32(8):1182-9. doi: 10.1097/PAS.0b013e318163a8f8.

DOI:10.1097/PAS.0b013e318163a8f8
PMID:18580680
Abstract

Signet-ring cell carcinoma (SRCC) is a unique subtype of adenocarcinoma that is characterized by abundant intracellular mucin accumulation and a crescent-shaped nucleus displaced toward one end of the cell. Identification of an SRCC's primary site is important for better planning of patient management because the treatment and prognosis differs markedly depending on the origin of the SRCC. In the present study, we analyzed the immunohistochemical characteristics of 94 cases of SRCC, including 21 cases of gastric SRCC, 16 of colorectal SRCC, 10 of breast SRCC, and 47 of pulmonary SRCC, with antibodies against Reg IV and claudin-18, which we previously identified as gastric cancer-related genes. We also tested known markers cytokeratin 7, cytokeratin 20, MUC2, MUC5AC, caudal-related homeobox gene 2 (CDX2), thyroid transcription factor-1, mammaglobin, gross cystic disease fluid protein 15, and estrogen receptor. All 21 cases of gastric SRCC and 16 cases of colorectal SRCC were positive for Reg IV, and the remaining SRCCs were negative. Eighteen of 21 (86%) gastric SRCCs and 6 of 16 (38%) colorectal SRCCs were positive for claudin-18, whereas another SRCCs were negative. In conclusion, Reg IV staining and claudin-18 staining can aid in diagnosis of gastrointestinal SRCC.

摘要

印戒细胞癌(SRCC)是腺癌的一种独特亚型,其特征是细胞内有大量粘蛋白积聚,细胞核呈新月形并向细胞一端移位。确定SRCC的原发部位对于更好地规划患者管理很重要,因为根据SRCC的起源不同,其治疗方法和预后有显著差异。在本研究中,我们用针对Reg IV和claudin-18的抗体分析了94例SRCC的免疫组化特征,这两种抗体我们之前鉴定为与胃癌相关的基因。我们还检测了已知标志物细胞角蛋白7、细胞角蛋白20、MUC2、MUC5AC、尾型相关同源盒基因2(CDX2)、甲状腺转录因子-1、乳腺珠蛋白、巨大囊肿病液体蛋白15和雌激素受体。所有21例胃SRCC和16例结直肠SRCC的Reg IV均呈阳性,其余SRCC为阴性。21例胃SRCC中有18例(86%)和16例结直肠SRCC中有6例(38%)的claudin-18呈阳性,而其他SRCC为阴性。总之,Reg IV染色和claudin-18染色有助于胃肠道SRCC的诊断。

相似文献

1
Immunohistochemical staining of Reg IV and claudin-18 is useful in the diagnosis of gastrointestinal signet ring cell carcinoma.Reg IV和claudin-18的免疫组织化学染色在胃肠道印戒细胞癌的诊断中具有重要作用。
Am J Surg Pathol. 2008 Aug;32(8):1182-9. doi: 10.1097/PAS.0b013e318163a8f8.
2
Expression and localization of Reg IV in human neoplastic and non-neoplastic tissues: Reg IV expression is associated with intestinal and neuroendocrine differentiation in gastric adenocarcinoma.Reg IV在人肿瘤组织和非肿瘤组织中的表达与定位:Reg IV表达与胃腺癌的肠型和神经内分泌分化相关。
J Pathol. 2005 Oct;207(2):185-98. doi: 10.1002/path.1827.
3
Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.通过细胞质黏液的存在来表征的肺印戒细胞癌、产生黏液的实性腺癌及黏液性细支气管肺泡癌免疫表型的比较。
J Pathol. 2006 May;209(1):78-87. doi: 10.1002/path.1947.
4
Primary signet-ring cell carcinoma of the lung: histochemical and immunohistochemical characterization.原发性肺印戒细胞癌:组织化学和免疫组织化学特征
Hum Pathol. 1999 Apr;30(4):378-83. doi: 10.1016/s0046-8177(99)90111-9.
5
An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases.胃和结直肠原发性印戒细胞癌的免疫组织化学研究:II. MUC1、MUC2、MUC5AC和MUC6在正常黏膜及42例病例中的表达
Int J Clin Exp Pathol. 2013;6(4):613-21. Epub 2013 Mar 15.
6
Primary signet-ring cell carcinoma of the lung with histochemical characterization.具有组织化学特征的原发性肺印戒细胞癌。
Anticancer Res. 2002 Mar-Apr;22(2B):1079-81.
7
The role of Reg IV gene and its encoding product in gastric carcinogenesis.Reg IV基因及其编码产物在胃癌发生中的作用。
Hum Pathol. 2010 Jan;41(1):59-69. doi: 10.1016/j.humpath.2009.06.013. Epub 2009 Sep 8.
8
Primary signet-ring cell carcinoma of lung: immunohistochemical study and comparison with non-pulmonary signet-ring cell carcinomas.原发性肺印戒细胞癌:免疫组织化学研究及与非肺印戒细胞癌的比较
Am J Surg Pathol. 2001 Dec;25(12):1515-9. doi: 10.1097/00000478-200112000-00007.
9
Immunohistochemical characterization of signet-ring cell carcinomas of the stomach, breast, and colon.胃、乳腺和结肠印戒细胞癌的免疫组织化学特征
Am J Clin Pathol. 2004 Jun;121(6):884-92. doi: 10.1309/A09E-RYMF-R64N-ERDW.
10
Chromogranin A expression correlates with tumour cell type and prognosis in signet ring cell carcinoma of the stomach.嗜铬粒蛋白A表达与胃印戒细胞癌的肿瘤细胞类型及预后相关。
Histopathology. 2008 Feb;52(3):305-13. doi: 10.1111/j.1365-2559.2007.02950.x.

引用本文的文献

1
Treatment Selection for Patients with HER2-Negative Metastatic Gastric Cancer Expressing Claudin 18.2 and PD-L1.Claudin 18.2和PD-L1表达阳性的HER2阴性转移性胃癌患者的治疗选择
Cancers (Basel). 2025 Mar 27;17(7):1120. doi: 10.3390/cancers17071120.
2
Identification of Hepatocellular Carcinoma Subtypes Based on Global Gene Expression Profiling to Predict the Prognosis and Potential Therapeutic Drugs.基于全基因表达谱鉴定肝细胞癌亚型以预测预后和潜在治疗药物
Biomedicines. 2025 Jan 20;13(1):236. doi: 10.3390/biomedicines13010236.
3
Claudin 18.2 Expression in 1404 Digestive Tract Adenocarcinomas Including 1175 Colorectal Carcinomas: Distinct Colorectal Carcinoma Subtypes Are Claudin 18.2 Positive.
Claudin 18.2在1404例消化道腺癌(包括1175例结直肠癌)中的表达:不同的结直肠癌亚型Claudin 18.2呈阳性。
Mod Pathol. 2025 May;38(5):100712. doi: 10.1016/j.modpat.2025.100712. Epub 2025 Jan 16.
4
Theranostic Approaches for Gastric Cancer: An Overview of In Vitro and In Vivo Investigations.胃癌的诊疗一体化方法:体外和体内研究综述
Cancers (Basel). 2024 Sep 28;16(19):3323. doi: 10.3390/cancers16193323.
5
Molecular genetic analysis of colorectal carcinoma with an aggressive extraintestinal immunohistochemical phenotype.结直肠癌具有侵袭性的肠外免疫组织化学表型的分子遗传学分析。
Sci Rep. 2024 Sep 27;14(1):22241. doi: 10.1038/s41598-024-72687-3.
6
The Expression of the Claudin Family of Proteins in Colorectal Cancer.Claudin 家族蛋白在结直肠癌中的表达。
Biomolecules. 2024 Feb 24;14(3):272. doi: 10.3390/biom14030272.
7
Claudin 18.2 as a New Biomarker in Gastric Cancer-What Should We Know?Claudin 18.2作为胃癌的新型生物标志物——我们应该了解什么?
Cancers (Basel). 2024 Feb 5;16(3):679. doi: 10.3390/cancers16030679.
8
Emerging targets in gastroesophageal adenocarcinoma: what the future looks like.胃食管腺癌的新兴靶点:未来展望
Ther Adv Med Oncol. 2023 May 13;15:17588359231173177. doi: 10.1177/17588359231173177. eCollection 2023.
9
REG4 promotes the proliferation and anti-apoptosis of cancer.REG4促进癌症的增殖和抗凋亡。
Front Cell Dev Biol. 2022 Sep 12;10:1012193. doi: 10.3389/fcell.2022.1012193. eCollection 2022.
10
Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy.Claudin18.2是一种用于肿瘤靶向免疫治疗的新型分子生物标志物。
Biomark Res. 2022 May 31;10(1):38. doi: 10.1186/s40364-022-00385-1.